The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Clinical Features of Early-Onset Alzheimer Disease in a Large Kindred With an E280A Presenilin-1 Mutation
Abstract
OBJECTIVES: To characterize clinical features of a very large pedigree with early-onset Alzheimer disease (AD) in which all affected individuals carry the identical glutamic acid-to-alanine mutation at codon 280 in the presenilin-1 gene. DESIGN: Clinical histories were obtained by patient and family interviews and through medical or civil records. Using standard diagnostic criteria, a case series of 128 individuals was identified, of which 6 have definitive (autopsy-proven) early-onset AD, 93 have probable early-onset AD, and 29 have possible early-onset AD. SETTING: Community based in Antioquia, Colombia. PATIENTS: A population-based sample in which all members of 5 extended families (nearly 3000 individuals) were surveyed. Criteria for inclusion required obtaining sufficient information to categorize the individual as affected. MAIN OUTCOME MEASURES: Age at onset, neuropsychological profile, neurologic history, and examination. RESULTS: The patients had a mean age at onset of 46.8 years (range, 34-62 years). The average interval until death was 8 years. Headache was noted in affected individuals significantly more frequently than in those not affected. The most frequent presentation was memory loss followed by behavior and personality changes and progressive loss of language ability. In the final stages, gait disturbances, seizures, and myoclonus were frequent. CONCLUSIONS: Other than the early onset, this clinical phenotype is indistinguishable from sporadic AD except that affected individuals frequently complained of headache preceding and during the disease. Despite the uniform genetic basis for the disease, there was significant variability in the age at onset, suggesting an important role for environmental factors or genetic modifiers in determining the age at onset.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Large ADAD families such as the kindred harboring the Colombian PSEN1 NM_000021:c.839A>C,p. (Glu280Ala) (canonically known as PSEN1 E280A) mutation, the world's largest ADAD founder population with a comprehensive family tree of thousands of individuals [3], provide an opportunity to assess the contribution of genetic variation to unexplained variability in age of dementia onset.”
From Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred (2023) · cites this paper as [3]
In the citing paper
“This study addresses these limitations by employing a well-described phenotype in a geographically isolated population with a monogenic form of AD [3].”
From Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred (2023) · cites this paper as [3]
In the citing paper
“For the past three decades, we have studied the world's largest known pedigree in which a presenilin-1 (PSEN1) mutation (p.Glu280Ala, E280A), often referred as the Paisa mutation, dominantly cosegregates with early-onset of Alzheimer's disease (AD).1”
From APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease (2016) · cites this paper as [1]
In the citing paper
“Our present study mitigates most of these confounders by using an expertly phenotyped, geographically isolated founder population affected with a monogenic early-onset form of AD.8”
From Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease (2015) · cites this paper as [8]
In the citing paper
“The age at clinical onset of autosomal dominant Alzheimer’s disease is similar between generations14 and is affected mostly by the mutation type and background family genetics.15”
From Clinical and biomarker changes in dominantly inherited Alzheimer's disease (2012) · cites this paper as [14]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
(1998) · Cited by 4,172
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
Reitan, R. M., & Wolfson, D. E. (1993) · Medical Entomology and Zoology · Cited by 3,413
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
The spectrum of behavioral changes in Alzheimer's disease
Mega, M., Cummings, J., Fiorello, T., & Gornbein, J. (1996) · Neurology · doi:10.1212/wnl.46.1.130 · Cited by 1,124
Hendriks, L., van Duijn, C. M., Cras, P. P., Cruts, M., Hul, W. V., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J., et al. (1992) · Nature Genetics · doi:10.1038/ng0692-218 · Cited by 741
Lemere, C. A., Lopera, F., Kosik, K. S., Lendon, C. L., Ossa, J., Saido, T. C., Yamaguchi, H., Ruiz, A., Martinez, A., Madrigal, L., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1146 · Cited by 487
Self-citationClark, R. F., Hutton, M., Fuldner, M., Froelich, S., Karran, E., Talbot, C., Crook, R., Lendon, C., Prihar, G., He, C., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-219 · Cited by 474
Self-citationPrevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study
White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437
Seizures and myoclonus in patients with Alzheimer's disease
Hauser, W. A., Morris, M. L., Heston, L. L., & Anderson, V. E. (1986) · Neurology · doi:10.1212/wnl.36.9.1226 · Cited by 336
A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
Kamboh, M. I., Sanghera, D. K., Ferrell, R. E., & DeKosky, S. T. (1995) · Nature Genetics · doi:10.1038/ng0895-486 · Cited by 336
Neuropsychological assessment in illiterates: Visuospatial and memory abilities
Ardila, A., Rosselli, M., & Rosas, P. (1989) · Brain and Cognition · doi:10.1016/0278-2626(89)90015-8 · Cited by 283
Wragg, M. A., Talbot, C. J., Hutton, M., & Goate, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91140-x · Cited by 243
Directions of research in cross-cultural neuropsychology
Ardila, A. (1995) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803399508406589 · Cited by 237
Neuropsychological Evaluation of the Spanish Speaker
Ardila, A., Rosselli, M., & Puente, A. E. (1994) · Critical issues in neuropsychology · doi:10.1007/978-1-4899-1453-8 · Cited by 232
The nucleus basalis of Meynert in neurological disease: A quantitative morphological study
Rogers, J., BROGAN, D. R., & Mirra, S. S. (1985) · Annals of Neurology · doi:10.1002/ana.410170210 · Cited by 202
Neuropsychological assessment in illiterates
Rosselli, M., Ardila, A., & Rosas, P. (1990) · Brain and Cognition · doi:10.1016/0278-2626(90)90020-o · Cited by 187
Presenilins and Alzheimer disease
Broeckhoven, C. V. (1995) · Nature Genetics · doi:10.1038/ng1195-230 · Cited by 187
Mann, D. M. A., Iwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400205 · Cited by 184
Seizures in Alzheimer's Disease: Clinicopathologic Study
Mendez, M. F., Catanzaro, P., Doss, R. C., Arguello, R., & Frey, W. H. (1994) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879400700407 · Cited by 182
Koss, E., Edland, S., Fillenbaum, G., Mohs, R., Clark, C., Galasko, D., & Morris, J. C. (1996) · Neurology · doi:10.1212/wnl.46.1.136 · Cited by 150
Neuropsychological characteristics of normal aging
Ardila, A., & Rosselli, M. (1989) · Developmental Neuropsychology · doi:10.1080/87565648909540441 · Cited by 147
Genetic studies in Alzheimer's disease with an NACP/α‐synuclein polymorphism
Xia, Y., de Silva, H. A. R., Rosi, B. L., Yamaoka, L. H., Rimmler, J. B., Pericak‐Vance, M. A., Roses, A. D., Chen, X., Masliah, E., DeTeresa, R. M., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410400212 · Cited by 120
Ardila, A., & Rosselli, M. (1994) · Developmental Neuropsychology · doi:10.1080/87565649409540571 · Cited by 109
Phenotype of chromosome 14–linked familial Alzheimer's disease in a large kindred
Lampe, T. H., Bird, T. D., Nochlin, D., Nemens, E. J., Risse, S. C., Sumi, S. M., Koerker, R. M., Leaird, B., Wier, M., & Raskind, M. A. (1994) · Annals of Neurology · doi:10.1002/ana.410360308 · Cited by 102
Epileptic Seizures in Elderly Patients with Dementia
McAreavey, M. J., Ballinger, B. R., & Fenton, G. W. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb02343.x · Cited by 100
Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description
Haltia, M., Viitanen, M. H., Sulkava, R. O., Ala‐Hurula, V., Pöyhönen, M., Goldfarb, L. G., Brown, P., Levy, E., Houlde, H., Crook, R., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360307 · Cited by 98
Presenilins and Alzheimer's disease
Kim, T.-W., & Tanzi, R. E. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80089-x · Cited by 97
MULLAN, M. J., Tsuji, S., Miki, T., Katsuya, T., Naruse, S., Kaneko, K., Shimizu, T., Kojima, T., Nakano, I., Ogihara, T., et al. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90099-w · Cited by 89
Chromosome 14 linked familial Alzheimer's disease
Kennedy, A. M., Newman, S., Frackowiak, R. S. J., Cunningham, V. J., Roques, P. K., Stevens, J., Neary, D., Bruton, C. J., Warrington, E. K., & Rossor, M. N. (1995) · Brain · doi:10.1093/brain/118.1.185 · Cited by 88
Effects of age, education, and gender on the Rey-osterrieth complex figure
Rosselli, M., & Ardila, A. (1991) · The Clinical Neuropsychologist · doi:10.1080/13854049108404104 · Cited by 85
Erkinjuntti, T. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb03599.x · Cited by 67
Normative data on the boston diagnostic aphasia examination in a spanish-speaking population
Rosselli, M., Ardila, A., Florez, A., & Castro, C. (1990) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639008400977 · Cited by 64
Schottky, J. (1932) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02864363 · Cited by 59
Li, J., Ma, J., & Potter, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12180 · Cited by 56
Müller, U., Bödeker, R., Gerundt, I., & Kurz, A. (1996) · Neurology · doi:10.1212/wnl.47.6.1575 · Cited by 47
A large pedigree with early-onset Alzheimer's disease
Campion, D., Brice, A., Hannequin, D., Tardieu, S., Dubois, B., Calenda, A., Brun, E., Penet, C., Tayot, J.-L., Martinez, M. M., et al. (1995) · Neurology · doi:10.1212/wnl.45.1.80 · Cited by 45
The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease
Chen, X., Xia, Y., Alford, M. F., DeTeresa, R. M., Hansen, L. A., Klauber, M. R., Katzman, R., Thal, L. J., Masliah, E., & Saitoh, T. (1995) · Annals of Neurology · doi:10.1002/ana.410380415 · Cited by 35
Demencia tipo Alzheimer con agregación familiar en Antioquia, Colombia
Restrepo, F. J. L., Burgos, O. M. A., Zapata, L., Kosik, K. H., Ochoa, J. W. C., & Londoño, J. E. O. (1994) · Institutional Repository University of Antioquia (University of Antioquia) · Cited by 23
Characteristics of familial Alzheimer's disease in nine kindreds of Volga German ancestry.
Bird, T. D., Lampe, T. H., Nemens, E. J., Sumi, S. M., Nochlin, D., Schellenberg, G. D., & Wijsman, E. M. (1989) · PubMed · Cited by 19
Descripción de una familia con demencia presenil tipo Alzheimer
Restrepo, F. J. L., Cornejo, W., Salinas, M. C. R., & Uribe, C. S. (1987) · AMC. Acta médica colombiana · Cited by 16
Bird, T. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360303 · Cited by 12
Cited by
Sorted by citations
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
The Amyloid-β Pathway in Alzheimer’s Disease
Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233
Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Metadata
- Authors
- Lopera, F.
- Affiliations
- Universidad de Antioquia (CO)
- Corresponding author
- Lopera, Francisco
- ORCID
- Lopera, Francisco
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 793
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2110985141
- Cited by
- 351
- References
- 52
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 19 · 2023: 17 · 2022: 8 · 2021: 14 · 2020: 16 · 2019: 16 · 2018: 13 · 2017: 13 · 2016: 19 · 2015: 22 · 2014: 21 · 2013: 14 · 2012: 23
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- early-onset Alzheimer's disease, presenilin 1, PSEN1 E280A mutation, familial Alzheimer's disease, clinical phenotype, age of onset, headache, memory loss, behavioral and personality changes, language loss, gait disturbance, seizures, myoclonus, genetic modifiers, extended family
- MeSH terms
- Adult, Alanine, Alzheimer Disease, Autopsy, Brain, Codon, Female, Headache, Humans, Male, Membrane Proteins, Middle Aged, Neuropsychological Tests, Pedigree, Phenotype, Point Mutation, Age of Onset, Glutamic Acid, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review